The effect of dornase alfa on ventilation inhomogeneity in patients with cystic fibrosis

Outcome measures to assess therapeutic interventions in cystic fibrosis (CF) patients with mild lung disease are lacking. Our aim was to determine if the lung clearance index (LCI) can detect a treatment response to dornase alfa in paediatric CF patients with normal spirometry. CF patients between 6...

Full description

Saved in:
Bibliographic Details
Published in:The European respiratory journal Vol. 37; no. 4; p. 806
Main Authors: Amin, R, Subbarao, P, Lou, W, Jabar, A, Balkovec, S, Jensen, R, Kerrigan, S, Gustafsson, P, Ratjen, F
Format: Journal Article
Language:English
Published: England 01.04.2011
Subjects:
Adolescent
Burkholderia cepacia - metabolism
Child
Cross-Over Studies
Cystic Fibrosis - drug therapy
Deoxyribonuclease I - pharmacology
Female
Humans
Lung - pathology
Male
Placebos
Research Design
Respiratory Function Tests
Spirometry - methods
Time Factors
Ventilation
ISSN:1399-3003, 1399-3003
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Outcome measures to assess therapeutic interventions in cystic fibrosis (CF) patients with mild lung disease are lacking. Our aim was to determine if the lung clearance index (LCI) can detect a treatment response to dornase alfa in paediatric CF patients with normal spirometry. CF patients between 6-18 yrs of age with FEV(1 )≥ 80% pred were eligible. In a crossover design, 17 patients received 4 weeks of dornase alfa and placebo in a randomised sequence separated by a 4-week washout period. The primary end-point was the change in LCI from dornase alfa versus placebo. A mixed model approach incorporating period-dependent baselines was used. The mean ± sd age was 10.32 ± 3.35 yrs. Dornase alfa improved LCI versus placebo (0.90 ± 1.44; p = 0.022). Forced expiratory flow at 25-75% expired volume measured by % pred and z-scores also improved in subjects on dornase alfa (6.1% ± 10.34%; p = 0.03 and 0.28 ± 0.46 z-score; p = 0.03). Dornase alfa significantly improved LCI. Therefore the LCI may be a suitable tool to assess early intervention strategies in this patient population.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
ISSN:1399-3003
1399-3003
DOI:10.1183/09031936.00072510